DK34287D0 - Tetrahydrocarbazol-l-alkansyre og farmaceutisk praeparat indeholdende en saadan forbindelse - Google Patents

Tetrahydrocarbazol-l-alkansyre og farmaceutisk praeparat indeholdende en saadan forbindelse

Info

Publication number
DK34287D0
DK34287D0 DK034287A DK34287A DK34287D0 DK 34287 D0 DK34287 D0 DK 34287D0 DK 034287 A DK034287 A DK 034287A DK 34287 A DK34287 A DK 34287A DK 34287 D0 DK34287 D0 DK 34287D0
Authority
DK
Denmark
Prior art keywords
tetrahydrocarbazol
compound
pharmaceutical preparation
preparation containing
alkanic acid
Prior art date
Application number
DK034287A
Other languages
English (en)
Other versions
DK168007B1 (da
DK34287A (da
Inventor
Yvan Guindon
John Gillard
Christiane Yoakim
Original Assignee
Merck Frosst Canada Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Frosst Canada Inc filed Critical Merck Frosst Canada Inc
Publication of DK34287D0 publication Critical patent/DK34287D0/da
Publication of DK34287A publication Critical patent/DK34287A/da
Application granted granted Critical
Publication of DK168007B1 publication Critical patent/DK168007B1/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/80[b, c]- or [b, d]-condensed
    • C07D209/82Carbazoles; Hydrogenated carbazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/80[b, c]- or [b, d]-condensed
    • C07D209/82Carbazoles; Hydrogenated carbazoles
    • C07D209/86Carbazoles; Hydrogenated carbazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the ring system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/80[b, c]- or [b, d]-condensed
    • C07D209/82Carbazoles; Hydrogenated carbazoles
    • C07D209/88Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Reproductive Health (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK034287A 1986-01-23 1987-01-22 1,9-disubstituerede 1,2,3,4-tetrahydrocarbazoler og farmaceutiske praeparater indeholdende saadanne forbindelser DK168007B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US82172686A 1986-01-23 1986-01-23
US82172686 1986-01-23

Publications (3)

Publication Number Publication Date
DK34287D0 true DK34287D0 (da) 1987-01-22
DK34287A DK34287A (da) 1987-07-24
DK168007B1 DK168007B1 (da) 1994-01-17

Family

ID=25234152

Family Applications (1)

Application Number Title Priority Date Filing Date
DK034287A DK168007B1 (da) 1986-01-23 1987-01-22 1,9-disubstituerede 1,2,3,4-tetrahydrocarbazoler og farmaceutiske praeparater indeholdende saadanne forbindelser

Country Status (14)

Country Link
EP (1) EP0234708B1 (da)
JP (1) JPS62223169A (da)
KR (1) KR870007117A (da)
AT (1) ATE61047T1 (da)
AU (1) AU592615B2 (da)
DE (1) DE3768097D1 (da)
DK (1) DK168007B1 (da)
ES (1) ES2038653T3 (da)
GR (1) GR3001828T3 (da)
IE (1) IE59861B1 (da)
IL (1) IL81325A (da)
NZ (1) NZ218999A (da)
PT (1) PT84178B (da)
ZA (1) ZA87468B (da)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4808608A (en) * 1986-01-23 1989-02-28 Merck & Co., Inc. Tetrahydrocarbazole 1-alkanoic acids, pharmaceutical compositions and use
AU633563B2 (en) * 1986-02-21 1993-02-04 Bayer Yakuhin, Ltd. Cycloalkanonesulphonamides
US4988820A (en) * 1986-02-21 1991-01-29 Bayer Aktiengesellschaft Cycloalkano(1,2-B) indole-sulponamides
DE3786030T2 (de) * 1986-03-27 1993-12-02 Merck Frosst Canada Inc Tetrahydrocarbazole Ester.
US4940719A (en) * 1986-03-27 1990-07-10 Merck Frosst Canada, Inc. Tetrahydrocarbazole esters, pharmaceutical compositions and use
EP0307077A1 (en) * 1987-07-21 1989-03-15 Merck Frosst Canada Inc. Tetrahydrocarbazoles for the improvement of cyclosporin therapy
GB8924392D0 (en) * 1989-10-30 1989-12-20 Bayer Ag Substituted cycloalkano/b/dihydroindole-and-indolesulphonamides
GB9101375D0 (en) * 1991-01-22 1991-03-06 Erba Carlo Spa N-imidazolyl derivatives of substituted tetrahydrocarbazole and cyclohepht(b)indole
MX9700696A (es) * 1994-07-27 1997-04-30 Sankyo Co Compuestos heterociclicos, utiles como productores de efecto aloesterico en receptores muscarinicos.
DE4435477A1 (de) * 1994-10-04 1996-04-11 Bayer Ag Cycloalkano-indol- und -azaindol-derivate
DE19615119A1 (de) * 1996-04-17 1997-10-23 Bayer Ag Neue Arylessigsäureamide
DE19615265A1 (de) * 1996-04-18 1997-12-04 Bayer Ag Neue Pyridazino-, Pyrimido-, Pyrazino- und Triazino-indole
US6410583B1 (en) * 2000-07-25 2002-06-25 Merck Frosst Canada & Co. Cyclopentanoindoles, compositions containing such compounds and methods of treatment
US7067148B2 (en) 2001-02-15 2006-06-27 King Pharmaceutical Research & Development, Inc. Stabilized pharmaceutical and thyroid hormone compositions and method of preparation
US7101569B2 (en) 2001-08-14 2006-09-05 Franz G Andrew Methods of administering levothyroxine pharmaceutical compositions
AR038136A1 (es) 2002-01-24 2004-12-29 Merck Frosst Canada Inc Cicloalcanindoles con sustitucion con fluor composiciones que contienen estos compuestos y metodos de tratamiento
US20080153817A1 (en) * 2003-08-07 2008-06-26 Dirk Beher Treatment for Alzheimer's Disease and Related Conditions
US7019022B2 (en) * 2003-12-15 2006-03-28 Merck Frosst Canada & Co. Substituted tetrahydrocarbazole and cyclopentanoindole derivatives
JP5841361B2 (ja) * 2011-06-29 2016-01-13 壽製薬株式会社 三環性化合物及びそれを含有する医薬組成物
EP4125874A4 (en) * 2020-03-25 2024-05-01 SRI International LIPOXYGENASE INHIBITORS

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA715217B (en) * 1970-08-20 1972-04-26 Org Nv Anti-inflammatory preparations
AR205331A1 (es) * 1972-07-24 1976-04-30 Hoffmann La Roche Procedimiento para la preparacion de carbazoles
US4057559A (en) * 1973-10-01 1977-11-08 American Home Products Corporation Carbazole acetic acid derivatives
GB1511169A (en) * 1975-08-29 1978-05-17 American Home Prod Trycyclic acetic acid derivatives
US4616028A (en) * 1985-04-22 1986-10-07 American Home Products Corporation Substituted 2,3,4,9-tetrahydro-1H-carbazole-1-acetic acid derivatives, compositions and use

Also Published As

Publication number Publication date
IE870168L (en) 1987-07-23
AU592615B2 (en) 1990-01-18
ZA87468B (en) 1987-08-26
ATE61047T1 (de) 1991-03-15
AU6790887A (en) 1987-07-30
ES2038653T3 (es) 1993-08-01
IL81325A (en) 1990-11-29
EP0234708B1 (en) 1991-02-27
KR870007117A (ko) 1987-08-14
GR3001828T3 (en) 1992-11-23
JPS62223169A (ja) 1987-10-01
DE3768097D1 (de) 1991-04-04
EP0234708A1 (en) 1987-09-02
IE59861B1 (en) 1994-04-20
PT84178A (pt) 1987-02-01
DK168007B1 (da) 1994-01-17
NZ218999A (en) 1990-12-21
PT84178B (pt) 1990-06-29
IL81325A0 (en) 1987-08-31
DK34287A (da) 1987-07-24

Similar Documents

Publication Publication Date Title
DK34287D0 (da) Tetrahydrocarbazol-l-alkansyre og farmaceutisk praeparat indeholdende en saadan forbindelse
EP0300676A3 (en) Tetrahydrocarbazole 1-alkanoic acids
DK660887A (da) N-benzylindolforbindelse og farmaceutisk praeparat indeholdende en saadan forbindelse
NO176606C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive (kinolin-2-ylmetoksy)-indoler
GB2200708B (en) Node member for use in building a geodesic structure
NO904431D0 (no) Fremgangsmaate for fremstilling av fibrinogenreseptor-antagonister.
DE3688009D1 (de) Verfahren zum herstellen von kieselsaeure hoher reinheit.
ES2023509B3 (es) Producto granular (i).
EP0310179A3 (en) Tetrahydrocarbazole esters
DK153987A (da) Tetrahydrocarbazolester og farmacetisk praeparat indeholdende en saadan forbindelse
FR2494253B1 (fr) Procede de production de dioxyde de chlore, a partir d'une charge d'acide mixte
FI881892A7 (fi) Menetelmä uusien, terapeuttisesti käyttökelpoisten 1,2,5,6-tetrahydropyridiinijohdannaisten valmistamiseksi
IT1226746B (it) Elemento costruttivo, nonche' metodo per la produzione dello stesso.
BE896738A (fr) Procede pour solidariser les fils d'une tringle pour pneumatiques.
DE3678139D1 (de) Neue kristalline salze von aryloxy-propanolaminen, verfahren zu ihrer herstellung und ihre verwendung.
TR23890A (tr) Saf asit borik üretimine mahsus usul.
EP0165592A3 (en) Antitumor agents
PT86712A (pt) Process for preparing p-xylene having a purity of at least 99,5%
EP0267605A3 (en) Novel intermediate compounds in a process for producing 16-phenoxy- and 16-substituted phenoxy-9-keto-prostatrienoic acid derivatives
DE3787476D1 (de) Verfahren zur Produktion von 2-(4,4'-bis(Dimethylamino)-benzhydryl)-5-dimethylaminobenzoesäure.
PL266042A2 (en) Procedure for the production of 2,6-dimethylanilide of 1-n-butylpiperidine-2-carboxylic acid

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed